PKU HealthCare Corp.,Ltd. (SHE:000788)
China · Delayed Price · Currency is CNY 5.46
-0.16 (-2.85%)
May 21, 2026, 3:04 PM CST
PKU HealthCare Corp.,Ltd. Revenue
PKU HealthCare Corp.,Ltd. had revenue of 215.17M CNY in the quarter ending March 31, 2026, a decrease of -57.17%. This brings the company's revenue in the last twelve months to 1.20B, down -42.22% year-over-year. In the year 2025, PKU HealthCare Corp.,Ltd. had annual revenue of 1.48B, down -28.04%.
Revenue (ttm)
1.20B
Revenue Growth
-42.22%
P/S Ratio
2.72
Revenue / Employee
1.55M
Employees
772
Market Cap
3.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.48B | -577.64M | -28.04% |
| Dec 31, 2024 | 2.06B | -133.78M | -6.10% |
| Dec 31, 2023 | 2.19B | 116.44M | 5.61% |
| Jan 1, 2023 | 2.08B | -159.42M | -7.13% |
| Jan 1, 2022 | 2.24B | 259.35M | 13.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huaren Pharmaceutical | 1.33B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.11B |
| Hunan Hansen Pharmaceutical | 1.05B |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Harbin Medisan Pharmaceutical | 813.23M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |
| Tibet AIM Pharm. | 670.32M |
| Honz Pharmaceutical | 450.28M |